GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gabather AB (OSTO:GABA) » Definitions » Total Equity

Gabather AB (OSTO:GABA) Total Equity : kr-4.18 Mil (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Gabather AB Total Equity?

Gabather AB's total equity for the quarter that ended in Dec. 2024 was kr-4.18 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Gabather AB Total Equity Historical Data

The historical data trend for Gabather AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gabather AB Total Equity Chart

Gabather AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.91 10.96 3.44 0.49 -4.18

Gabather AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.49 -2.70 -3.57 -2.70 -4.18

Gabather AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Gabather AB's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=1.833-6.008
=-4.18

Gabather AB's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=1.833-6.008
=-4.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gabather AB Total Equity Related Terms

Thank you for viewing the detailed overview of Gabather AB's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Gabather AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gabather AB (OSTO:GABA) » Definitions » Total Equity
Comparable Companies
XSAT:DANCAN XSAT:PMED XSAT:ODI ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA ITCI SZSE:000538 UTHR BOM:500087 TSE:4507 SHSE:688506 NSE:TORNTPHARM
Traded in Other Exchanges
N/A
Address
Forskargatan 20J, Byggn 215 N, Sodertalje, SWE, 151 36
Website
https://www.gabather.com
Gabather AB is engaged in developing novel drugs to treat several diseases originating in the central nervous system. It has four main focus areas anti-psychotics, anti-depressants and anxiolytics, analgesics, as well as cognition-enhancing treatments, including for Alzheimer's disease.

Gabather AB Headlines

No Headlines